CHI Podcasts

Cambridge Healthtech Podcasts

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.

  1. Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

    15.01.2020

    Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

    Prof. Matthew Lungren shares his stories on how he got to where he is now and where his artificial intelligent inspiration for medicine comes from. He also talks about many great collaborations at the Stanford Center in precision medicine and what he’s looking to see more in this field in the next 5 years. For more information, please visit https://www.TriConference.com/Precision-Medicine

    24 Min.
  2. Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

    17.12.2019

    Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

    Gene therapy presents a promising path ahead for patients of rare diseases. The United States Food and Drug Administration’s Director of the Center for Biologics Evaluation and Research, Dr. Peter Marks discusses his work advancing production and availability of gene therapies for rare disorders, and the unique challenges to producing efficacious therapeutics in this field. For more information, please visit https://www.TriConference.com/Gene-Therapy

    14 Min.
  3. Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

    06.08.2019

    Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

    Nancy Sajjadi, an independent bioassay quality consultant with over 30 years of experience in biopharmaceutical product development, discusses her history in the bioassay field and how her experience has fostered her passion for teaching biostatistics to non-statisticians with CHI. Topics include: challenges in developing bioassays for cell & gene therapies, regulatory considerations and standards for bioassays, fostering collaboration between statisticians and bench scientists, and more For more information, please visit https://www.ImmunogenicitySummit.com/Workshop

    8 Min.
  4. Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

    05.06.2019

    Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

    Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health. For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics

    12 Min.
  5. the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

    26.03.2019

    the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

    Samuel Levy of Bluestar Genomics speaks to CHI on March 13, 2019. Dr. Levy will be speaking during The Liquid Biopsy Summit, June 17-19, in San Francisco, CA. Topics include cell-free diagnostics in precision medicine, transformation & growth in the liquid biopsy field, epigenomic assays for cancer detection, and opportunities ahead. For more information, please visit https://www.LiquidBiopsySummit.com/Programs

    12 Min.
  6. Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

    05.03.2019

    Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

    Dr. Konstantinos Mitsakakis explains the One Health approach, and how the pursuit benefits diverse avenues of diagnostic research. For more information, please visit https://www.MolecularDXEurope.com/Point-of-Care-Dx

    9 Min.
  7. Molecular Med Tri-Con 2019 | Putting the AI in Wait

    01.03.2019

    Molecular Med Tri-Con 2019 | Putting the AI in Wait

    Dr. Richard Levenson discusses the role of AI in digital pathology – what works, and what needs to be done for AI to reach its full potential. For more information, please visit https://www.TriConference.com/Digital-Pathology

    8 Min.
  8. Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

    18.02.2019

    Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

    Harry Glorikian interviews Niven R. Narain about his approach on how to add more precision to the process of drug development and diagnostic development while engage more reproducibility. Niven also discusses how to use the biomarkers not only as a readout but as a vehicle and an agent to design clinical trials much differently. For more information, please visit https://www.TriConference.com/Precision-Medicine

    10 Min.
Alle anzeigen (255)

Info

The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.

Informationen

  • Erstellt von
    Cambridge Healthtech Podcasts
  • Jahre aktiv
    2013 - 2020
  • Folgen
    255
  • Bewertung
    Unbedenklich
  • Copyright
    © All rights reserved
  • Sendungswebsite
    CHI Podcasts